A mass of evidence suggests that deregulation of the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway in hepatocytes is a common molecular mechanism involved in metabolic dysfunctions including obesity, metabolic syndrome, and NAFLD26. The gene discussed is AKT1; the disease is metabolic syndrome.